| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prolactin receptor binding | 6.10e-08 | 7 | 131 | 4 | GO:0005148 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 3.60e-07 | 10 | 131 | 4 | GO:0005131 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 DNAH10 ERCC6L ATAD5 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 ATP12A AQR | 3.44e-05 | 441 | 131 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 4.27e-05 | 2 | 131 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 4.27e-05 | 2 | 131 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 DNAH10 ERCC6L MYO7B ATAD5 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 ATP12A AQR SLC27A3 | 5.22e-05 | 614 | 131 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | hormone receptor binding | 7.04e-05 | 34 | 131 | 4 | GO:0051427 | |
| GeneOntologyMolecularFunction | helicase activity | 8.35e-05 | 158 | 131 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | RNA polymerase I core binding | 2.54e-04 | 4 | 131 | 2 | GO:0001042 | |
| GeneOntologyMolecularFunction | DNA translocase activity | 4.22e-04 | 5 | 131 | 2 | GO:0015616 | |
| GeneOntologyMolecularFunction | prostaglandin E receptor activity | 4.22e-04 | 5 | 131 | 2 | GO:0004957 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 6.09e-04 | 59 | 131 | 4 | GO:0031593 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 6.30e-04 | 6 | 131 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 6.42e-04 | 26 | 131 | 3 | GO:0070530 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 8.79e-04 | 65 | 131 | 4 | GO:0070063 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.08e-03 | 31 | 131 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 1.17e-03 | 8 | 131 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.19e-03 | 32 | 131 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | EFL1 ABCA2 DNAH10 ERCC6L ATAD5 ENPP1 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 ATP12A AQR | 1.24e-03 | 839 | 131 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | EFL1 ABCA2 DNAH10 ERCC6L ATAD5 ENPP1 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 ATP12A AQR | 1.25e-03 | 840 | 131 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | EFL1 ABCA2 DNAH10 ERCC6L ATAD5 ENPP1 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 ATP12A AQR | 1.25e-03 | 840 | 131 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.49e-03 | 9 | 131 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.51e-03 | 127 | 131 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | EFL1 ABCA2 DNAH10 ERCC6L ATAD5 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 ATP12A AQR | 1.77e-03 | 775 | 131 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 1.86e-03 | 10 | 131 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 1.86e-03 | 10 | 131 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 2.26e-03 | 11 | 131 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 2.26e-03 | 11 | 131 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.41e-03 | 206 | 131 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 2.70e-03 | 12 | 131 | 2 | GO:0004954 | |
| GeneOntologyBiologicalProcess | hormone biosynthetic process | 6.35e-08 | 83 | 133 | 8 | GO:0042446 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 1.07e-07 | 36 | 133 | 6 | GO:0046885 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 1.13e-06 | 13 | 133 | 4 | GO:0090031 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.97e-06 | 58 | 133 | 6 | GO:0032350 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone biosynthetic process | 5.94e-06 | 19 | 133 | 4 | GO:0046886 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 8.72e-06 | 209 | 133 | 9 | GO:0006694 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 1.15e-05 | 46 | 133 | 5 | GO:0032107 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 1.59e-05 | 24 | 133 | 4 | GO:0090030 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 2.07e-05 | 233 | 133 | 9 | GO:0061351 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 2.21e-05 | 26 | 133 | 4 | GO:0060396 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone metabolic process | 2.21e-05 | 26 | 133 | 4 | GO:0032352 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 2.58e-05 | 27 | 133 | 4 | GO:0071378 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 5.81e-05 | 104 | 133 | 6 | GO:0007405 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 6.46e-05 | 106 | 133 | 6 | GO:0050810 | |
| GeneOntologyBiologicalProcess | fibroblast proliferation | 8.14e-05 | 160 | 133 | 7 | GO:0048144 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.01e-04 | 286 | 133 | 9 | GO:0042445 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid biosynthetic process | 1.03e-04 | 38 | 133 | 4 | GO:0010893 | |
| GeneOntologyBiologicalProcess | photoreceptor cell outer segment organization | 1.13e-04 | 15 | 133 | 3 | GO:0035845 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 1.39e-04 | 41 | 133 | 4 | GO:0060416 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid metabolic process | 1.53e-04 | 42 | 133 | 4 | GO:0045940 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | ABCA2 ENPP1 CYP11B1 CYP11B2 CYP27B1 GH1 GH2 HSD3B7 CSH1 CSH2 | 1.66e-04 | 376 | 133 | 10 | GO:0008202 |
| GeneOntologyBiologicalProcess | positive regulation of multicellular organism growth | 2.38e-04 | 47 | 133 | 4 | GO:0040018 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 2.44e-04 | 135 | 133 | 6 | GO:0019218 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 2.46e-04 | 4 | 133 | 2 | GO:0002017 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 2.50e-04 | 87 | 133 | 5 | GO:0033143 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.54e-04 | 136 | 133 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.42e-04 | 202 | 133 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 3.76e-04 | 95 | 133 | 5 | GO:0002090 | |
| GeneOntologyBiologicalProcess | D-glucose transmembrane transport | 4.00e-04 | 148 | 133 | 6 | GO:1904659 | |
| GeneOntologyBiologicalProcess | hexose transmembrane transport | 4.45e-04 | 151 | 133 | 6 | GO:0008645 | |
| GeneOntologyBiologicalProcess | monosaccharide transmembrane transport | 4.94e-04 | 154 | 133 | 6 | GO:0015749 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 5.11e-04 | 155 | 133 | 6 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | 5.29e-04 | 156 | 133 | 6 | GO:0048259 | |
| GeneOntologyBiologicalProcess | response to food | 5.35e-04 | 58 | 133 | 4 | GO:0032094 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via JAK-STAT | 5.35e-04 | 58 | 133 | 4 | GO:0046427 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 5.43e-04 | 25 | 133 | 3 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 5.43e-04 | 25 | 133 | 3 | GO:0050962 | |
| GeneOntologyBiologicalProcess | regulation of D-glucose transmembrane transport | 5.96e-04 | 105 | 133 | 5 | GO:0010827 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 2.33e-08 | 6 | 133 | 4 | GO:0070195 | |
| MousePheno | decreased pituitary gland weight | 2.48e-07 | 8 | 110 | 4 | MP:0008938 | |
| MousePheno | absent somatotrophs | 4.44e-07 | 9 | 110 | 4 | MP:0008330 | |
| MousePheno | absent lactotrophs | 4.44e-07 | 9 | 110 | 4 | MP:0008333 | |
| MousePheno | abnormal pituitary gland size | 8.62e-07 | 42 | 110 | 6 | MP:0008936 | |
| MousePheno | increased circulating ghrelin level | 1.71e-06 | 12 | 110 | 4 | MP:0011612 | |
| MousePheno | abnormal pituitary gland weight | 1.71e-06 | 12 | 110 | 4 | MP:0008937 | |
| MousePheno | abnormal circulating ghrelin level | 4.63e-06 | 15 | 110 | 4 | MP:0011611 | |
| MousePheno | decreased lactotroph cell number | 7.98e-06 | 17 | 110 | 4 | MP:0008332 | |
| MousePheno | abnormal lactotroph morphology | 1.28e-05 | 19 | 110 | 4 | MP:0008323 | |
| MousePheno | decreased somatotroph cell number | 1.96e-05 | 21 | 110 | 4 | MP:0008329 | |
| MousePheno | increased brown adipose tissue amount | 2.09e-05 | 43 | 110 | 5 | MP:0000005 | |
| MousePheno | small adenohypophysis | 2.86e-05 | 23 | 110 | 4 | MP:0008321 | |
| MousePheno | abnormal somatotroph morphology | 3.42e-05 | 24 | 110 | 4 | MP:0008322 | |
| MousePheno | increased white adipose tissue amount | 5.33e-05 | 52 | 110 | 5 | MP:0000008 | |
| MousePheno | abnormal urine progesterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011546 | |
| MousePheno | delayed vaginal opening | 6.42e-05 | 28 | 110 | 4 | MP:0002636 | |
| MousePheno | disproportionate dwarf | 8.32e-05 | 57 | 110 | 5 | MP:0002427 | |
| MousePheno | small pituitary gland | 8.50e-05 | 30 | 110 | 4 | MP:0005361 | |
| MousePheno | abnormal timing of vaginal opening | 9.70e-05 | 31 | 110 | 4 | MP:0020150 | |
| MousePheno | increased neural tube apoptosis | 1.25e-04 | 33 | 110 | 4 | MP:0012505 | |
| MousePheno | abnormal circulating hormone level | CAND2 RASGRF1 CD248 CYP11B1 CYP11B2 GPR42 CYP27B1 PTGER1 PTGER3 GH1 GH2 KCNA3 CSH1 CSH2 HELZ2 TRAPPC10 PAPPA BBS12 HDC | 1.51e-04 | 954 | 110 | 19 | MP:0005418 |
| MousePheno | increased renin activity | 1.62e-04 | 14 | 110 | 3 | MP:0005582 | |
| MousePheno | increased circulating hormone level | CD248 CYP11B1 CYP11B2 GPR42 CYP27B1 GH1 GH2 CSH1 CSH2 HELZ2 TRAPPC10 PAPPA BBS12 HDC | 1.73e-04 | 578 | 110 | 14 | MP:0014456 |
| MousePheno | abnormal iris transillumination | 1.83e-04 | 3 | 110 | 2 | MP:0012122 | |
| MousePheno | abnormal hormone level | CAND2 RASGRF1 CD248 CYP11B1 CYP11B2 GPR42 CYP27B1 PTGER1 PTGER3 GH1 GH2 KCNA3 CSH1 CSH2 HELZ2 TRAPPC10 PAPPA HPS5 BBS12 HDC | 2.40e-04 | 1073 | 110 | 20 | MP:0003953 |
| MousePheno | decreased spleen weight | 2.64e-04 | 113 | 110 | 6 | MP:0004953 | |
| MousePheno | abnormal adrenocorticotropin level | 2.94e-04 | 41 | 110 | 4 | MP:0003966 | |
| MousePheno | fetal growth retardation | 3.05e-04 | 116 | 110 | 6 | MP:0004201 | |
| MousePheno | decreased heart weight | 3.34e-04 | 118 | 110 | 6 | MP:0002834 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 3.64e-04 | 4 | 110 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 3.64e-04 | 4 | 110 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 3.64e-04 | 4 | 110 | 2 | MP:0011539 | |
| MousePheno | decreased foot pigmentation | 3.64e-04 | 4 | 110 | 2 | MP:0011568 | |
| MousePheno | abnormal urine corticosterone level | 3.64e-04 | 4 | 110 | 2 | MP:0011548 | |
| MousePheno | thickened long bone epiphysis | 3.64e-04 | 4 | 110 | 2 | MP:0000132 | |
| MousePheno | decreased urine hormone level | 3.64e-04 | 4 | 110 | 2 | MP:0014459 | |
| MousePheno | impaired glucose tolerance | RASGRF1 CYP11B1 CYP11B2 GPR42 CHD8 NEDD4 GH1 GH2 CSH1 CSH2 COMMD9 HDC | 3.89e-04 | 480 | 110 | 12 | MP:0005293 |
| MousePheno | abnormal brown adipose tissue amount | 4.64e-04 | 82 | 110 | 5 | MP:0001778 | |
| MousePheno | abnormal renin activity | 4.90e-04 | 20 | 110 | 3 | MP:0005581 | |
| MousePheno | increased hormone level | CD248 CYP11B1 CYP11B2 GPR42 CYP27B1 GH1 GH2 CSH1 CSH2 HELZ2 TRAPPC10 PAPPA BBS12 HDC | 4.94e-04 | 641 | 110 | 14 | MP:0014454 |
| MousePheno | delayed sexual maturation | 5.86e-04 | 49 | 110 | 4 | MP:0001938 | |
| MousePheno | increased adrenal gland zona fasciculata size | 6.04e-04 | 5 | 110 | 2 | MP:0014286 | |
| MousePheno | abnormal pituitary gland morphology | 6.84e-04 | 135 | 110 | 6 | MP:0000633 | |
| MousePheno | abnormal fetal growth/weight/body size | 7.90e-04 | 312 | 110 | 9 | MP:0004197 | |
| MousePheno | oliguria | 8.51e-04 | 24 | 110 | 3 | MP:0003620 | |
| MousePheno | uterus adenomyosis | 9.02e-04 | 6 | 110 | 2 | MP:0009221 | |
| MousePheno | increased urine hormone level | 9.02e-04 | 6 | 110 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 9.02e-04 | 6 | 110 | 2 | MP:0009078 | |
| MousePheno | decreased fasting circulating glucose level | 1.01e-03 | 200 | 110 | 7 | MP:0013278 | |
| MousePheno | decreased circulating mineral level | CAND2 ENPP1 CYP11B1 CYP11B2 CYP27B1 SEC31B SLC26A1 AKAP9 NUB1 ATP12A | 1.02e-03 | 391 | 110 | 10 | MP:0014548 |
| MousePheno | abnormal urine homeostasis | CYP11B1 CYP11B2 CYP27B1 LAMA5 PTGER1 PTGER3 SLC26A1 PRODH2 SLC22A1 ATP12A HPS5 | 1.10e-03 | 466 | 110 | 11 | MP:0009643 |
| MousePheno | abnormal urine hormone level | 1.26e-03 | 7 | 110 | 2 | MP:0011538 | |
| MousePheno | hypochlorhydria | 1.26e-03 | 7 | 110 | 2 | MP:0008001 | |
| MousePheno | pituitary gland hyperplasia | 1.26e-03 | 7 | 110 | 2 | MP:0000635 | |
| MousePheno | abnormal kidney weight | 1.27e-03 | 208 | 110 | 7 | MP:0002707 | |
| MousePheno | decreased bone mineral density | ENPP1 CYP27B1 YTHDC2 CUL7 SLC39A13 NEDD4 GH1 GH2 CSH1 CSH2 PAPPA | 1.30e-03 | 476 | 110 | 11 | MP:0000063 |
| Domain | SOMATOTROPIN_2 | 3.12e-08 | 6 | 128 | 4 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 3.12e-08 | 6 | 128 | 4 | PS00266 | |
| Domain | Hormone_1 | 3.12e-08 | 6 | 128 | 4 | PF00103 | |
| Domain | Somatotropin | 7.25e-08 | 7 | 128 | 4 | IPR001400 | |
| Domain | Somatotropin_CS | 3.11e-06 | 5 | 128 | 3 | IPR018116 | |
| Domain | Cyt_P450_mitochondrial | 4.66e-05 | 2 | 128 | 2 | IPR002399 | |
| Domain | Prostglndn_DP_rcpt | 1.39e-04 | 3 | 128 | 2 | IPR001244 | |
| Domain | PHD_4 | 1.39e-04 | 3 | 128 | 2 | PF16866 | |
| Domain | HEAT | 3.24e-04 | 48 | 128 | 4 | PF02985 | |
| Domain | 4_helix_cytokine_core | 4.10e-04 | 51 | 128 | 4 | IPR012351 | |
| Domain | AAA | 4.75e-04 | 144 | 128 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 4.75e-04 | 144 | 128 | 6 | IPR003593 | |
| Domain | - | EFL1 ABCA2 DNAH10 ERCC6L MYO7B MFHAS1 ATAD5 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 AQR | 6.01e-04 | 746 | 128 | 14 | 3.40.50.300 |
| Domain | HEAT | 6.71e-04 | 58 | 128 | 4 | IPR000357 | |
| Domain | LRR_8 | 1.17e-03 | 171 | 128 | 6 | PF13855 | |
| Domain | Prostanoid_rcpt | 1.27e-03 | 8 | 128 | 2 | IPR008365 | |
| Domain | 4_helix_cytokine-like_core | 1.67e-03 | 74 | 128 | 4 | IPR009079 | |
| Domain | - | 1.68e-03 | 321 | 128 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 1.92e-03 | 328 | 128 | 8 | IPR032675 | |
| Domain | P-loop_NTPase | EFL1 ABCA2 DNAH10 ERCC6L MYO7B MFHAS1 ATAD5 MCM7 YTHDC2 CHD8 MDN1 FBH1 HELZ2 AQR | 2.03e-03 | 848 | 128 | 14 | IPR027417 |
| Domain | ZF_CXXC | 2.46e-03 | 11 | 128 | 2 | PS51058 | |
| Domain | Znf_CXXC | 2.46e-03 | 11 | 128 | 2 | IPR002857 | |
| Domain | zf-CXXC | 2.46e-03 | 11 | 128 | 2 | PF02008 | |
| Domain | ARM-like | 2.61e-03 | 270 | 128 | 7 | IPR011989 | |
| Domain | Leu-rich_rpt | 2.67e-03 | 271 | 128 | 7 | IPR001611 | |
| Domain | ATPase_dyneun-rel_AAA | 4.02e-03 | 14 | 128 | 2 | IPR011704 | |
| Domain | AAA_5 | 4.02e-03 | 14 | 128 | 2 | PF07728 | |
| Domain | LRR_1 | 4.02e-03 | 219 | 128 | 6 | PF00560 | |
| Domain | - | 4.30e-03 | 222 | 128 | 6 | 1.25.10.10 | |
| Domain | - | 4.87e-03 | 50 | 128 | 3 | 1.20.1250.10 | |
| Domain | FBOX | 5.44e-03 | 52 | 128 | 3 | SM00256 | |
| Domain | LRRNT | 5.74e-03 | 53 | 128 | 3 | PF01462 | |
| Domain | Cyt_P450_CS | 5.74e-03 | 53 | 128 | 3 | IPR017972 | |
| Domain | HEAT_type_2 | 5.93e-03 | 17 | 128 | 2 | IPR021133 | |
| Domain | SUSHI | 6.69e-03 | 56 | 128 | 3 | PS50923 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.13e-06 | 13 | 107 | 4 | MM14516 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 5.32e-06 | 16 | 107 | 4 | MM15710 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 1.11e-05 | 19 | 107 | 4 | MM1513 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 1.38e-05 | 20 | 107 | 4 | MM15070 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 4.12e-05 | 26 | 107 | 4 | MM1345 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 6.44e-05 | 29 | 107 | 4 | MM1522 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.08e-04 | 33 | 107 | 4 | MM1404 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.81e-04 | 15 | 107 | 3 | M552 | |
| Pubmed | 2.30e-10 | 4 | 137 | 4 | 7169009 | ||
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 1.15e-09 | 5 | 137 | 4 | 31479305 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 10767558 | ||
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 1.15e-09 | 5 | 137 | 4 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 1.15e-09 | 5 | 137 | 4 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 1.15e-09 | 5 | 137 | 4 | 16508206 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 18006625 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 15616010 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 1.15e-09 | 5 | 137 | 4 | 32556100 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 1.15e-09 | 5 | 137 | 4 | 11346667 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 12010633 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 1.15e-09 | 5 | 137 | 4 | 17626886 | |
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 1.15e-09 | 5 | 137 | 4 | 24218587 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 19359380 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 1.15e-09 | 5 | 137 | 4 | 16201410 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 15316240 | ||
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 1.15e-09 | 5 | 137 | 4 | 11487592 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 11318985 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 1.15e-09 | 5 | 137 | 4 | 18203262 | |
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 1.15e-09 | 5 | 137 | 4 | 17272398 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 20707609 | ||
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 1.15e-09 | 5 | 137 | 4 | 2249485 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 17242167 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 18180319 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 1874564 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 1.15e-09 | 5 | 137 | 4 | 12225773 | |
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 1.15e-09 | 5 | 137 | 4 | 32100023 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 3780533 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 10395045 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 1.15e-09 | 5 | 137 | 4 | 8552145 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 1.15e-09 | 5 | 137 | 4 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 1.15e-09 | 5 | 137 | 4 | 8647448 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 26887678 | ||
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 1.15e-09 | 5 | 137 | 4 | 10810296 | |
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 1.15e-09 | 5 | 137 | 4 | 8756530 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 31099824 | ||
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 1.15e-09 | 5 | 137 | 4 | 7965203 | |
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 1.15e-09 | 5 | 137 | 4 | 1980158 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 1.15e-09 | 5 | 137 | 4 | 23861378 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 1.15e-09 | 5 | 137 | 4 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 1.15e-09 | 5 | 137 | 4 | 11350075 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 18617616 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 17347312 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 1.15e-09 | 5 | 137 | 4 | 10974531 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 21852148 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 12175649 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 15070902 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 23428905 | ||
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 1.15e-09 | 5 | 137 | 4 | 24758742 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 1.15e-09 | 5 | 137 | 4 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 1.15e-09 | 5 | 137 | 4 | 23639351 | |
| Pubmed | 1.15e-09 | 5 | 137 | 4 | 21098290 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 1.15e-09 | 5 | 137 | 4 | 17761891 | |
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 1.15e-09 | 5 | 137 | 4 | 18948397 | |
| Pubmed | The human growth hormone locus: nucleotide sequence, biology, and evolution. | 3.44e-09 | 6 | 137 | 4 | 2744760 | |
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 12399427 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 14596666 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 3.44e-09 | 6 | 137 | 4 | 20032199 | |
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 11316754 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 11309401 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 23150490 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 2991252 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 25017732 | ||
| Pubmed | Third party data gene data set of eutherian growth hormone genes. | 3.44e-09 | 6 | 137 | 4 | 26697363 | |
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 10689811 | ||
| Pubmed | Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. | 3.44e-09 | 6 | 137 | 4 | 15985453 | |
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 20863500 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 24949662 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 33539533 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 20231469 | ||
| Pubmed | Growth hormone resistance: clinical states and animal models. | 3.44e-09 | 6 | 137 | 4 | 10556764 | |
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 12208853 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 9175714 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 16141391 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 18618017 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 12166626 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 9275086 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 23782652 | ||
| Pubmed | Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. | 3.44e-09 | 6 | 137 | 4 | 14759511 | |
| Pubmed | Age related changes in gene expression within the cochlea of C57BL/6J mice. | 3.44e-09 | 6 | 137 | 4 | 23010755 | |
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 25645493 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 15166120 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 24691732 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 21725989 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 38951485 | ||
| Pubmed | Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. | 3.44e-09 | 6 | 137 | 4 | 14530511 | |
| Pubmed | Growth hormone controls lipolysis by regulation of FSP27 expression. | 3.44e-09 | 6 | 137 | 4 | 30400015 | |
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 26862561 | ||
| Pubmed | 3.44e-09 | 6 | 137 | 4 | 21849508 | ||
| Cytoband | 17q24.2 | 1.96e-06 | 30 | 137 | 4 | 17q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 4.77e-04 | 120 | 137 | 4 | chr17q23 | |
| GeneFamily | Growth hormone family | 8.94e-09 | 6 | 91 | 4 | 1175 | |
| GeneFamily | Cytochrome P450 family 11 | 7.49e-05 | 3 | 91 | 2 | 1007 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 8.82e-04 | 9 | 91 | 2 | 207 | |
| GeneFamily | UPF1 like RNA helicases | 1.34e-03 | 11 | 91 | 2 | 1169 | |
| GeneFamily | Zinc fingers CXXC-type | 1.60e-03 | 12 | 91 | 2 | 136 | |
| ToppCell | Mild|World / Disease group and Cell class | 2.43e-06 | 196 | 136 | 7 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 2.43e-06 | 196 | 136 | 7 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 2.43e-06 | 196 | 136 | 7 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | 11.5-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 1.64e-05 | 175 | 136 | 6 | d8ca8fbe5309dab293c335b32f1b138edfdd0b07 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 175 | 136 | 6 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 175 | 136 | 6 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | COVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster | 1.64e-05 | 175 | 136 | 6 | 83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15 | |
| ToppCell | COVID-mDC1|COVID / Condition, Cell_class and T cell subcluster | 1.64e-05 | 175 | 136 | 6 | b9280444016e21c28131a61df65cc5c56d402412 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 178 | 136 | 6 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 178 | 136 | 6 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 181 | 136 | 6 | 382337427be3c11ecd03e9fa2c2e831a9674c6a7 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.54e-05 | 189 | 136 | 6 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 3.20e-05 | 197 | 136 | 6 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 2.15e-09 | 5 | 136 | 4 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 1.49e-08 | 7 | 136 | 4 | DOID:0060870 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 4.17e-07 | 14 | 136 | 4 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.96e-06 | 22 | 136 | 4 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Glucocorticoid-remediable aldosteronism | 2.11e-05 | 2 | 136 | 2 | C1260386 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 2.11e-05 | 2 | 136 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 3.13e-05 | 39 | 136 | 4 | DOID:9744 (implicated_via_orthology) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 6.31e-05 | 3 | 136 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | IGFBP-3 measurement | 1.14e-04 | 54 | 136 | 4 | EFO_0004626 | |
| Disease | X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide measurement | 1.26e-04 | 4 | 136 | 2 | EFO_0021186 | |
| Disease | Ciliopathies | 1.60e-04 | 110 | 136 | 5 | C4277690 | |
| Disease | sexual dimorphism measurement | ANKRD31 SEC16B DNAH10 RASGRF1 CD248 ATAD5 TSC2 DYSF GH1 PARP10 CEP120 CSH1 RRN3 PAPPA GCN1 | 1.85e-04 | 1106 | 136 | 15 | EFO_0021796 |
| Disease | scavenger receptor class F member 1 measurement | 2.09e-04 | 5 | 136 | 2 | EFO_0008276 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 2.09e-04 | 5 | 136 | 2 | DOID:446 (is_implicated_in) | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 2.80e-04 | 68 | 136 | 4 | EFO_0007826, EFO_0007860 | |
| Disease | Conn Syndrome | 3.13e-04 | 6 | 136 | 2 | C1384514 | |
| Disease | Abnormality of vision | 3.13e-04 | 6 | 136 | 2 | C4025846 | |
| Disease | Hyperaldosteronism | 3.13e-04 | 6 | 136 | 2 | C0020428 | |
| Disease | heart septal defect | 3.13e-04 | 6 | 136 | 2 | MONDO_0002078 | |
| Disease | Retinitis pigmentosa | 3.87e-04 | 74 | 136 | 4 | cv:C0035334 | |
| Disease | protocadherin alpha-7 measurement | 4.36e-04 | 7 | 136 | 2 | EFO_0801973 | |
| Disease | acisoga measurement | 4.36e-04 | 7 | 136 | 2 | EFO_0800068 | |
| Disease | protein FAM163B measurement | 7.43e-04 | 9 | 136 | 2 | EFO_0802936 | |
| Disease | sleep apnea | 8.35e-04 | 40 | 136 | 3 | EFO_0003877 | |
| Disease | androstenedione measurement | 9.26e-04 | 10 | 136 | 2 | EFO_0007972 | |
| Disease | Russell-Silver syndrome | 9.26e-04 | 10 | 136 | 2 | C0175693 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.13e-03 | 11 | 136 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.13e-03 | 11 | 136 | 2 | EFO_0021862 | |
| Disease | Retinitis Pigmentosa | 1.39e-03 | 104 | 136 | 4 | C0035334 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.44e-03 | 264 | 136 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | Short Rib-Polydactyly Syndrome | 1.59e-03 | 13 | 136 | 2 | C0036996 | |
| Disease | N-acetyl-isoputreanine measurement | 1.59e-03 | 13 | 136 | 2 | EFO_0800107 | |
| Disease | Saldino-Noonan Syndrome | 1.85e-03 | 14 | 136 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.85e-03 | 14 | 136 | 2 | C0024507 | |
| Disease | HOMA-B | 2.11e-03 | 55 | 136 | 3 | EFO_0004469 | |
| Disease | Generalized hypotonia | 2.13e-03 | 15 | 136 | 2 | C1858120 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 2.22e-03 | 56 | 136 | 3 | EFO_0022250 | |
| Disease | cholesterol in IDL measurement | 2.46e-03 | 58 | 136 | 3 | EFO_0021899 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.84e-03 | 61 | 136 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Disorder of eye | 3.07e-03 | 212 | 136 | 5 | C0015397 | |
| Disease | Tourette syndrome, schizophrenia | 3.07e-03 | 18 | 136 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | prion disease | 3.43e-03 | 19 | 136 | 2 | EFO_0004720 | |
| Disease | metabolonic lactone sulfate measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0800659 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.74e-03 | 222 | 136 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | free cholesterol in large VLDL measurement | 3.86e-03 | 68 | 136 | 3 | EFO_0022265 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.96e-03 | 225 | 136 | 5 | EFO_0008317, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLLEEIRWSNPEFSL | 946 | Q96QE3 | |
| LARLLTAPELILDQW | 561 | Q9BSJ8 | |
| ERVFSPQELLWLDEL | 926 | Q96Q91 | |
| DWRGELLLALQQVFL | 3021 | Q99996 | |
| ELLLLQERQRASEWP | 2141 | Q9HCK8 | |
| DLWNFLDIPRSRLVK | 251 | Q9NR81 | |
| QLSEPLLWFILRVLD | 3076 | Q9NR09 | |
| LLRDRDWINQVYLPE | 366 | Q96QU6 | |
| LNALLQWLLRPLVLY | 301 | Q9H2F3 | |
| QRDDRWLLVALLVPT | 681 | Q9HCU0 | |
| LRQAWLENIRPVLVI | 131 | Q7Z2Z2 | |
| EVPWTLQELEALLLR | 96 | A6QL63 | |
| EALLPTRRWFNTILD | 261 | O60306 | |
| LLLQLREELAAVWRE | 491 | Q8N283 | |
| TLAPLDFLLQRKRLW | 26 | Q8N1D0 | |
| LRQLPSLVNAWERAL | 711 | Q9NVE4 | |
| WERALKPIQLREALL | 721 | Q9NVE4 | |
| KPIQLREALLARLEW | 726 | Q9NVE4 | |
| EAWRRALDLVLLVLQ | 671 | Q6ZW61 | |
| LPALRLLDLRWIEDV | 531 | Q6PCT2 | |
| QELLSQELWRRLLPG | 516 | Q9UF12 | |
| RLRRLLWDLEQQELP | 936 | Q5U651 | |
| PALIWQQQRELAELR | 951 | Q6P2E9 | |
| RWLQVLGELQRLLLD | 1056 | Q6DT37 | |
| LTQFLREDRIQLWKP | 11 | Q9Y5A7 | |
| LEDLIRYLEPERWQL | 196 | Q9NRA1 | |
| LEEKELPWRRLLFDQ | 26 | Q8N7Z5 | |
| GEEWQRLRSLLAPLL | 131 | O15528 | |
| LRDWNLIRDAATLIL | 461 | P19113 | |
| LLQAWGLILRANILE | 2861 | Q9NU22 | |
| WILENDPTELDLRFI | 1106 | P46934 | |
| LFLWRELQEAPLSLA | 561 | O43292 | |
| LLTLWLDNNRIRYLP | 321 | Q9Y4C4 | |
| LWSLIPNNDVRRLVS | 31 | Q49AS3 | |
| AEALWELPSLQSLRL | 131 | Q9HBX8 | |
| RNIPPQLRWEVLDSL | 86 | Q9NZI8 | |
| QFLRLLLLWVPASRG | 6 | A0A0C4DH26 | |
| EGFLPRTLINLRVEW | 891 | P54707 | |
| ESLLQPESLRLDWLL | 911 | Q9UPZ3 | |
| LLLIESWLEPVRFLR | 106 | P0DML3 | |
| DLLFHQRIQISLWPR | 86 | C9JC47 | |
| LDPWVYILLRQAVLR | 346 | P34995 | |
| SLNQILDPWVYLLLR | 336 | P43115 | |
| RVILLENLTRFWPII | 931 | Q14999 | |
| LPRRDFQRQVWLLFE | 211 | P22001 | |
| LSKLRELWLRNNPIE | 146 | Q9HBW1 | |
| PILDRFLLNVLDRAW | 11 | Q9H2C1 | |
| FEERILAVLQWLQLP | 346 | P22413 | |
| LLPQLEQGLFDDLWR | 1816 | Q92616 | |
| QLLRTLAEVERLLWE | 2311 | O15230 | |
| GNLLILITVWADPRL | 41 | Q8NGC4 | |
| DLELPRDAFTLQVWL | 111 | Q13219 | |
| LEFWKDQLAILLPVR | 171 | O15529 | |
| LPRLKQELQQARWLD | 891 | P29375 | |
| QLPAALLSRFDLLWL | 506 | P33993 | |
| LLSRFDLLWLIQDRP | 511 | P33993 | |
| ALWPRDALLFAVDNL | 121 | Q8TCU5 | |
| ARNLAIVWAPNLLRS | 461 | O14559 | |
| NQISLPRLVDLDWRV | 116 | Q9P000 | |
| VLEARQDLSLRPLIW | 561 | Q8N0W3 | |
| QDLSLRPLIWAAVRE | 566 | Q8N0W3 | |
| LRLWLEDRTPEALLQ | 96 | P14770 | |
| LDLLFHQRIQISLWP | 86 | P0CG42 | |
| WDPETLALLLREELQ | 576 | Q14674 | |
| LDRIIDIWILLQPEE | 781 | Q8NFZ0 | |
| RQRWPLLLLGLAVVT | 21 | P15814 | |
| LSWLINRLPGLRDLV | 1141 | Q8NHM5 | |
| RLEEQLPWLSLRALK | 146 | Q8N9W5 | |
| LQDTFLRIPLLVELW | 521 | Q8N960 | |
| LGQPRDLLLLWRQAV | 221 | H7BZ55 | |
| EWRFNRLRLNPEVLS | 136 | P15538 | |
| LDSVARNPQELWRFL | 151 | Q9BZC7 | |
| EWRFNRLRLNPDVLS | 136 | P19099 | |
| LLLDSNIRLWVVLPI | 6 | Q9P0I2 | |
| SRPDRVALETQWLQL | 641 | Q8WXE1 | |
| LLELVELQRWPEAAA | 1831 | Q9BYK8 | |
| ALVVLQELVRALWPL | 541 | O75155 | |
| LLLIESWLEPVRFLR | 106 | P0DML2 | |
| RIWQNDILEREIPLS | 3376 | Q8IVF4 | |
| RLREVWQALPLILFA | 486 | O15245 | |
| LEEEDPWRSLQQLLL | 341 | Q96H72 | |
| PAALEQAEDWLLRLR | 766 | O75923 | |
| DLIIWIRLVPLQEEI | 366 | Q2NKX8 | |
| AFRELPLQLLLDGQW | 346 | Q96A99 | |
| LRQRFVASWALLPDV | 491 | Q68BL7 | |
| EVLLQEVREDLAWPL | 241 | A6NGG8 | |
| APRWLEEEAALQLAL | 646 | Q53GL7 | |
| ARNLAIVWAPNLLRS | 166 | Q7Z6I6 | |
| READRLLSLWAPQVQ | 491 | Q6QHF9 | |
| VQLLIWIPRLAQALL | 136 | Q92521 | |
| FEQLISIILRLPWLN | 106 | Q9NYV6 | |
| RLLFNDPDLREVWLN | 1066 | Q9NRR4 | |
| WRFRAELAEQLILLL | 756 | Q8TF05 | |
| SLLLPWQNRLRNEIE | 121 | B4DZS4 | |
| RLENVWLPLFLASEQ | 961 | Q8NE09 | |
| LWKELVLFLRPRSQL | 296 | Q5UE93 | |
| DRLPVIQLWDLRFAS | 236 | Q9NQW1 | |
| LPNLRELWLDRNQLS | 196 | Q14160 | |
| LLPEEWDEITLRFIN | 471 | A4IF30 | |
| AIPARWLRSLELLFA | 701 | Q13972 | |
| DWEGLLELLQARLPR | 1581 | Q9H2D6 | |
| QSSARELRPLLVFIW | 481 | Q8N122 | |
| LWLALDTAQRPEQLI | 161 | O43868 | |
| DTRPGLRLLLWLEQN | 151 | Q14028 | |
| LRRWADLLLVAPLDA | 91 | Q96CD2 | |
| LQLLAAVELFNRDWR | 456 | Q9NZN8 | |
| PLLERWLGNLLARQF | 646 | Q6P2Q9 | |
| LLLIQSWLEPVQLLR | 106 | P01242 | |
| LPNVSLAWVIEALRL | 66 | Q86UV6 | |
| QVLALLWPRFELILE | 471 | Q8N1B4 | |
| WTLLQQFPRLELLDL | 681 | Q9NR97 | |
| SRVRYWDLLLLIPNV | 41 | Q86W33 | |
| VREALQSDWLPFELL | 366 | Q9BZV1 | |
| IPLQLRGEVWALLLE | 101 | Q92738 | |
| RWLRPELLSKEQILE | 91 | Q53GI3 | |
| FLAILPEELQAWLRE | 96 | Q86W11 | |
| LQPRIRLAQGLWLLS | 11 | Q03395 | |
| VRALVQDLLPATRWL | 46 | Q9H2B4 | |
| LRWLPADLAFAVRAL | 26 | Q5K4L6 | |
| NRLLEDPVIKRFLAW | 56 | Q495Y7 | |
| PQRLLAVILWFQLAL | 26 | Q5VX71 | |
| LWRLLNESDKRPFIE | 141 | P56693 | |
| LLLIQSWLEPVQFLR | 106 | P01241 | |
| VWNNSRPIRLEEILE | 346 | Q86WI1 | |
| FEQLISIILRLPWLN | 106 | A6NIE6 | |
| LFANVLEPVLDRDRW | 516 | Q6ZUG5 | |
| LEPDWLAQLRRQLEQ | 696 | Q96JE7 | |
| PVLRFDALWQVLARD | 301 | Q14142 | |
| LEPLVGEQLLQLWER | 1406 | Q9H6S0 | |
| LPNVSLAWVIEALRL | 66 | Q86UV7 | |
| RVWQTLLVLFPRLDQ | 1171 | Q13395 | |
| REFPLQDLLVVWDAL | 341 | Q92609 | |
| LSQAPEAWRLFLLLA | 86 | A0AVI4 | |
| TLLLFLQRPWEVAQR | 316 | P48553 | |
| LQRPWEVAQRALELL | 321 | P48553 | |
| LARIPEWGQDLQLLL | 496 | Q96PF1 | |
| PRLWRLLAEAALQKL | 696 | Q9P2L0 | |
| WDLSVELQINPRALL | 46 | Q9Y4E6 | |
| LQVLATEAPRLLLWF | 531 | Q9H347 | |
| EWILLDPVQRNLYRD | 26 | Q96MR9 | |
| VAWDILLNIIERLLQ | 356 | P49815 | |
| LQPAVWRALLLDRRQ | 76 | Q5T230 | |
| PFTQVLEERQRLWLA | 281 | O15049 | |
| VVDAARLQWPLLFSR | 1396 | Q6PIF6 |